All lobbying filings
Green Mountain Strategies LLC DC
Green Mountain Strategies LLC DC filed a Q4 report for Alvogen on January 20, 2026, reporting no lobbying activity.
Lobbying for Alvogen · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
Filing · LD-2 quarterly report
Q4 reportNo activity
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Lobbying activity
0
No itemized activity in this filing.